Gene Winchester pioneered pre-blended, packaged concrete under the Gemaco Quikrete brand in 1951. His three sons took over the family business three decades later and helped build it into a privately-held giant. Full story: (Photo: Charles Krupa/AP)

🌟 Thank you to Gene Tsudik from UCI for an enlightening Keynote on “Staving off the IoT Armageddon” at ACM CCS 2024! A huge shoutout to our committee and all attendees for making this event a remarkable success! #acm_ccs#

UCLA professor Dr. Mete Civelek and his team have identified MYH9 as a female-biased gene linked to fibrous artery plaque formation, a finding that could reshape how heart disease is understood and treated in women.

May 18, 1969: Tom Stafford, John Young, and Gene Cernan begin the second crewed mission to the Moon. Apollo 10 was the final critical test flight before Apollo 11's lunar landing, just 2 months later.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mainstream. #Forbes250# Forbes has named Doudna to our list of America’s 250 Greatest Innovators. Read the full story on the Nobel laureate:

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mainstream. #Forbes250# Forbes has named Doudna to our list of America’s 250 Greatest Innovators. Read the full story on the Nobel laureate:

Forget killing cancer cells. South Korea just figured out how to talk them back into being normal. Scientists at KAIST in Daejeon have done something the world has been chasing for decades. They found a molecular switch that flips cancer cells back into healthy cells. No chemo. No radiation. No destroying anything. Just… reversal. Professor Kwang-Hyun Cho and his team caught cancer in the act. That tiny window where a normal cell is on the edge of turning malignant but hasn't fully crossed over yet. They call it the "critical transition" — the same kind of jump that happens when water hits 100°C and becomes steam. In that split-second window, the cell is unstable. Normal and cancerous at the same time. And that's exactly where they hit the switch. In colon cancer trials, they targeted three master genes — MYB, HDAC2, and FOXA2 — and the cancer cells didn't die. They went back to being healthy intestinal cells. Like nothing ever happened. The team built a digital twin of the gene network to map every move a cell makes on its way to becoming cancerous. Then they reverse-engineered the path home. Their paper landed in Advanced Science, published by Wiley. It's still early. Lab trials and mice. Human treatment is years away. But the idea of curing cancer without killing a single cell is no longer science fiction. Source: KAIST (Korea Advanced Institute of Science and Technology), published in Advanced Science journal

Six weeks after birth, “Yangyang” — the first somatic cell–cloned cat in East China — is healthy and thriving. A research team from Yangzhou University, a global leader in veterinary science, has tackled the challenge of low cloning efficiency with an innovative in vivo maturation technique. Combined with their latest breakthrough in gene editing, this advancement could pave the way for hypoallergenic cat breeds. Customized, allergy-free pets may soon become a reality — a purr-fect leap forward! @ChinaScience @SmithsonianMag